Orphan drug grant application
FDA announces in July 11 Federal Register that it is limiting receipt of grant applications for fiscal year 1991 to competitive renewal applications and approved unfunded applications received in response to FDA's solicitation for FY 1990. FDA is not soliciting grant applications for the current fiscal year because of an existing abundance of applications.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth